-
1
-
-
76749164888
-
Chemosensitization of cancer cells by siRNA using targeted nanogel delivery
-
Dickerson EB, Blackburn WH, Smith MH, et al. Chemosensitization of cancer cells by siRNA using targeted nanogel delivery. BMC Cancer 2010;10:1-11
-
(2010)
BMC Cancer
, vol.10
, pp. 1-11
-
-
Dickerson, E.B.1
Blackburn, W.H.2
Smith, M.H.3
-
2
-
-
3142514670
-
Progress in the development of nucleic acid therapeutics for cancer
-
Kalota A, Shetzline SE, Gewirtz AM. Progress in the development of nucleic acid therapeutics for cancer. Cancer Biol Ther 2004;3:4-12 (Pubitemid 41348538)
-
(2004)
Cancer Biology and Therapy
, vol.3
, Issue.1
, pp. 4-12
-
-
Kalota, A.1
Shetzline, S.E.2
Gewirtz, A.M.3
-
4
-
-
0037031576
-
Single-stranded antisense siRNAs guide target RNA cleavage in RNAi
-
DOI 10.1016/S0092-8674(02)00908-X
-
Martinez J, Patkaniowska A, Urlaub H, et al. Single-stranded antisense siRNAsguide target RNA cleavage in RNAi. Cell 2002;110:563-74 (Pubitemid 35247837)
-
(2002)
Cell
, vol.110
, Issue.5
, pp. 563-574
-
-
Martinez, J.1
Patkaniowska, A.2
Urlaub, H.3
Luhrmann, R.4
Tuschl, T.5
-
5
-
-
0032545933
-
Potent and specific genetic interference by double-stranded RNA in caenorhabditis elegans
-
DOI 10.1038/35888
-
Fire A, Xu S, Montgomery MK, et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998;391:806-11 (Pubitemid 28099681)
-
(1998)
Nature
, vol.391
, Issue.6669
, pp. 806-811
-
-
Fire, A.1
Xu, S.2
Montgomery, M.K.3
Kostas, S.A.4
Driver, S.E.5
Mello, C.C.6
-
6
-
-
0033572660
-
Targeted mRNA degradation by double-stranded RNA in vitro
-
DOI 10.1101/gad.13.24.3191
-
Tuschl T, Zamore PD, Lehmann R, et al. Targeted mRNA degradation by double-stranded RNA in vitro. Genes Dev 1999;13:3191-7 (Pubitemid 30030441)
-
(1999)
Genes and Development
, vol.13
, Issue.24
, pp. 3191-3197
-
-
Tuschl, T.1
Zamore, P.D.2
Lehmann, R.3
Bartel, D.P.4
Sharp, P.A.5
-
7
-
-
0033615491
-
A species of small antisense RNA in posttranscriptional gene silencing in plants
-
Hamilton AJ, Baulcombe DC. A species of small antisense RNA in posttranscriptional gene silencing in plants. Science 1999;286:950-2
-
(1999)
Science
, vol.286
, pp. 950-2
-
-
Hamilton, A.J.1
Baulcombe, D.C.2
-
8
-
-
4744373229
-
Noise amidst the silence: Off-target effects of siRNAs?
-
DOI 10.1016/j.tig.2004.08.006, PII S0168952504002409
-
Jackson AL, Linsley PS. Noise amidst the silence: off-targeteffects of siRNAs? Trends Genet 2004;20:521-4 (Pubitemid 39314555)
-
(2004)
Trends in Genetics
, vol.20
, Issue.11
, pp. 521-524
-
-
Jackson, A.L.1
Linsley, P.S.2
-
9
-
-
4444302947
-
Crystal structure of argonaute and its implications for RISC slicer activity
-
DOI 10.1126/science.1102514
-
Song JJ, Smith SK, Hannon GJ, et al. Crystal structure of Argonaute and its implications for RISC slicer activity. Science 2004;305:1434-7 (Pubitemid 39167656)
-
(2004)
Science
, vol.305
, Issue.5689
, pp. 1434-1437
-
-
Song, J.-J.1
Smith, S.K.2
Hannon, G.J.3
Joshua-Tor, L.4
-
10
-
-
36849044732
-
Nonviral delivery of synthetic siRNAs in vivo
-
DOI 10.1172/JCI33494
-
Akhtar S, Benter IF. Nonviral delivery of synthetic siRNAs in vivo. J Clin Invest 2007;117:3623-32 (Pubitemid 350224068)
-
(2007)
Journal of Clinical Investigation
, vol.117
, Issue.12
, pp. 3623-3632
-
-
Akhtar, S.1
Benter, I.F.2
-
12
-
-
0037031576
-
Single-stranded antisense siRNAs guide target RNA cleavage in RNAi
-
DOI 10.1016/S0092-8674(02)00908-X
-
Martinez J, Patkaniowska A, Urlaub H, et al. Single-stranded antisense siRNAs guide target RNA cleavage in RNAi. Cell 2002;110:563-74 (Pubitemid 35247837)
-
(2002)
Cell
, vol.110
, Issue.5
, pp. 563-574
-
-
Martinez, J.1
Patkaniowska, A.2
Urlaub, H.3
Luhrmann, R.4
Tuschl, T.5
-
13
-
-
33645167401
-
Prospects of RNA interference therapy for cancer
-
Pai SI, Lin YY, Macaes B, et al. Prospects of RNA interference therapy for cancer. Gene Ther 2006;13:464-77
-
(2006)
Gene Ther
, vol.13
, pp. 464-77
-
-
Pai, S.I.1
Lin, Y.Y.2
MacAes, B.3
-
14
-
-
77956552507
-
Carbonate apatite-facilitated intracellularly delivered siRNA for efficient knockdown of functional genes
-
Hossain S, Stanislaus A, Chua MJ, et al. Carbonate apatite-facilitated intracellularly delivered siRNA for efficient knockdown of functional genes. J Control Release 2010;147:101-8
-
(2010)
J Control Release
, vol.147
, pp. 101-8
-
-
Hossain, S.1
Stanislaus, A.2
Chua, M.J.3
-
15
-
-
4043181214
-
Cancer genes and the pathways they control
-
DOI 10.1038/nm1087
-
Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nat Med 2004;10:789-99 (Pubitemid 39070849)
-
(2004)
Nature Medicine
, vol.10
, Issue.8
, pp. 789-799
-
-
Vogelstein, B.1
Kinzler, K.W.2
-
16
-
-
1542515338
-
A census of human cancer genes
-
Futreal PA, Coin L, Marshall M, et al. A census of human cancer genes. Nat Rev Cancer 2004;4:177-83 (Pubitemid 38337497)
-
(2004)
Nature Reviews Cancer
, vol.4
, Issue.3
, pp. 177-183
-
-
Futreal, P.A.1
Coin, L.2
Marshall, M.3
Down, T.4
Hubbard, T.5
Wooster, R.6
Rahman, N.7
Stratton, M.R.8
-
17
-
-
0034789517
-
Receptor tyrosine kinase signalling as a target for cancer intervention strategies
-
DOI 10.1677/erc.0.0080161
-
Zwick E, Bange J, Ullrich A. Receptor tyrosine kinase signalling as a target for cancer intervention strategies. Endocr Relat Cancer 2001;8:161-73 (Pubitemid 32947638)
-
(2001)
Endocrine-Related Cancer
, vol.8
, Issue.3
, pp. 161-173
-
-
Zwick, E.1
Bange, J.2
Ullrich, A.3
-
18
-
-
0035902180
-
Oncogenic kinase signalling
-
DOI 10.1038/35077225
-
Blume-Jensen P, Hunter T. Oncogenic kinase signalling. Nature 2001;411:355-65 (Pubitemid 32467045)
-
(2001)
Nature
, vol.411
, Issue.6835
, pp. 355-365
-
-
Blume-Jensen, P.1
Hunter, T.2
-
19
-
-
0141790842
-
Inhibition of bcr-abl gene expression by small interfering RNA sensitizes for imatinib mesylate (STI571)
-
DOI 10.1182/blood-2002-12-3899
-
Wohlbold L, van der Kuip H, Miething C, et al. Inhibition of bcr-abl gene expression by small interfering RNA sensitizes for imatinib mesylate (STI571). Blood 2003;102:2236-9 (Pubitemid 37122404)
-
(2003)
Blood
, vol.102
, Issue.6
, pp. 2236-2239
-
-
Wohlbold, L.1
Van Der Kuip, H.2
Miething, C.3
Vornlocher, H.-P.4
Knabbe, C.5
Duyster, J.6
Aulitzky, W.E.7
-
20
-
-
3042725365
-
Stable expression of small interfering RNA sensitizes TEL-PDGFβR to inhibition with imatinib or rapamycin
-
DOI 10.1172/JCI200420673
-
Chen J, Wall NR, Kocher K, et al. Stable expression of small interfering RNA sensitizes TEL-PDGFbetaR to inhibition with imatinib or rapamycin. J Clin Invest 2004;113:1784-91 (Pubitemid 39071670)
-
(2004)
Journal of Clinical Investigation
, vol.113
, Issue.12
, pp. 1784-1791
-
-
Chen, J.1
Wall, N.R.2
Kocher, K.3
Duclos, N.4
Fabbro, D.5
Neuberg, D.6
Griffin, J.D.7
Shi, Y.8
Gilliland, D.G.9
-
21
-
-
4143066760
-
Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways
-
DOI 10.1126/science.1101637
-
Sordella R, Bell DW, Haber DA, Settleman J. Gefitinibsensitizing EGFR mutations in lung cancer activate antiapoptotic pathways. Science 2004;305:1163-7 (Pubitemid 39100331)
-
(2004)
Science
, vol.305
, Issue.5687
, pp. 1163-1167
-
-
Sordella, R.1
Bell, D.W.2
Haber, D.A.3
Settleman, J.4
-
22
-
-
1042289783
-
Inhibition of Breast and Ovarian Tumor Growth through Multiple Signaling Pathways by Using Retrovirus-mediated Small Interfering RNA against Her-2/neu Gene Expression
-
DOI 10.1074/jbc.M311153200
-
Yang G, Cai KQ, Thompson-Lanza JA, et al. Inhibition of breast and ovarian tumor growth through multiple signaling pathways by using retrovirus-mediated small interfering RNA against Her-2/neu gene expression. J Biol Chem 2004;279:4339-45 (Pubitemid 38199022)
-
(2004)
Journal of Biological Chemistry
, vol.279
, Issue.6
, pp. 4339-4345
-
-
Yang, G.1
Cai, K.Q.2
Thompson-Lanza, J.A.3
Bast Jr., R.C.4
Liu, J.5
-
23
-
-
0344825125
-
Small interfering RNA (siRNA) inhibits the expression of the Her2/Neu gene, upregulates HLA class I and induces apoptosis of Her2/Neu positive tumor cell lines
-
DOI 10.1002/ijc.11497
-
Choudhury A, Charo J, Parapuram SK, et al. Small interfering RNA (siRNA) inhibits the expression of the Her2/neu gene, upregulates HLA class I and induces apoptosis of Her2/neu positive tumor cell lines. Int J Cancer 2004;108:71-7 (Pubitemid 37444446)
-
(2004)
International Journal of Cancer
, vol.108
, Issue.1
, pp. 71-77
-
-
Choudhury, A.1
Charo, J.2
Parapuram, S.K.3
Hunt, R.C.4
Hunt, D.M.5
Seliger, B.6
Kiessling, R.7
-
24
-
-
16244409820
-
Inactivation of ErbB3 by siRNA promotes apoptosis and attenuates growth and invasiveness of human lung adenocarcinoma cell line A549
-
DOI 10.1038/sj.onc.1208381
-
Sithanandam G, Fornwald LW, Fields J, Anderson LM. Inactivation of ErbB3 by siRNA promotes apoptosis and attenuates growth and invasiveness of human lung adenocarcinoma cell line A549. Oncogene 2005;24:1847-59 (Pubitemid 40462787)
-
(2005)
Oncogene
, vol.24
, Issue.11
, pp. 1847-1859
-
-
Sithanandam, G.1
Fornwald, L.W.2
Fields, J.3
Anderson, L.M.4
-
25
-
-
66449091211
-
Dual silencing of insulin-like growth factor-I receptor and epidermal growth factor receptor in colorectal cancer cells is associated with decreased proliferation and enhanced apoptosis
-
Kaulfuss S, Burfeind P, Gaedcke J, et al. Dual silencing of insulin-like growth factor-I receptor and epidermal growth factor receptor in colorectal cancer cells is associated with decreased proliferation and enhanced apoptosis. Mol Cancer Ther 2009;8:821-33
-
(2009)
Mol Cancer Ther
, vol.8
, pp. 821-33
-
-
Kaulfuss, S.1
Burfeind, P.2
Gaedcke, J.3
-
26
-
-
0242624594
-
Growth factor receptors as therapeutic targets: Strategies to inhibit the insulin-like growth factor I receptor
-
Surmacz E. Growth factor receptors as therapeutic targets: strategies to inhibit the insulin-like growth factor I receptor. Oncogene 2003;22:6589-97 (Pubitemid 37372339)
-
(2003)
Oncogene
, vol.22
, Issue.43
, pp. 6589-6597
-
-
Surmacz, E.1
-
27
-
-
36549005467
-
Target validation using RNA interference in solid tumors
-
DOI 10.1385/1-59745-208-4:227, Target Discovery and Validation Reviews and Protocols: Volume 2 Emerging Molecular Targetsand Treatment Options
-
Aharinejad S, Sioud M, Lucas T, et al. Target validation using RNA interference in solid tumors. Methods Mol Biol 2007;361:227-38 (Pubitemid 350183210)
-
(2007)
Methods in Molecular Biology
, vol.361
, pp. 227-238
-
-
Aharinejad, S.1
Sioud, M.2
Lucas, T.3
Abraham, D.4
-
28
-
-
3442901908
-
Colony-stimulating factor-1 blockade by antisense oligonucleotides and small interfering RNAs suppresses growth of human mammary tumor xenografts in mice
-
DOI 10.1158/0008-5472.CAN-04-0961
-
Aharinejad S, Paulus P, Sioud M, et al. Colony-stimulating factor-1 blockade by antisense oligonucleotides and small interfering RNAs suppresses growth of human mammary tumor xenografts in mice. Cancer Res 2004;64:5378-84 (Pubitemid 39006559)
-
(2004)
Cancer Research
, vol.64
, Issue.15
, pp. 5378-5384
-
-
Aharinejad, S.1
Paulus, P.2
Sioud, M.3
Hofmann, M.4
Zins, K.5
Schafer, R.6
Stanley, E.R.7
Abraham, D.8
-
29
-
-
15944402069
-
RNAi-induced down-regulation of FLT3 expression in AML cell lines increases sensitivity to MLN518
-
DOI 10.1182/blood-2004-07-2758
-
Walters DK, Stoffregen EP, Heinrich MC, et al. RNAi-induced down-regulation of FLT3 expression in AML cell lines increases sensitivity to MLN518. Blood 2005;105:2952-4 (Pubitemid 40446291)
-
(2005)
Blood
, vol.105
, Issue.7
, pp. 2952-2954
-
-
Walters, D.K.1
Stoffregen, E.P.2
Heinrich, M.C.3
Deininger, M.W.4
Druker, B.J.5
-
30
-
-
1442308345
-
EphA2: A determinant of malignant cellular behavior and a potential therapeutic target in pancreatic adenocarcinoma
-
DOI 10.1038/sj.onc.1207247
-
Duxbury MS, Ito H, Zinner MJ, et al. EphA2: a determinant of malignant cellular behavior and a potential therapeutic target in pancreatic adenocarcinoma. Oncogene 2004;23:1448-56 (Pubitemid 38406840)
-
(2004)
Oncogene
, vol.23
, Issue.7
, pp. 1448-1456
-
-
Duxbury, M.S.1
Ito, H.2
Zinner, M.J.3
Ashley, S.W.4
Whang, E.E.5
-
31
-
-
2942607458
-
SiRNA directed against c-Src enhances pancreatic adenocarcinoma cell gemcitabine chemosensitivity
-
Duxbury MS, Ito H, Zinner MJ, et al. siRNA directed against c-Src enhances pancreatic adenocarcinoma cell gemcitabine chemosensitivity. J Am Coll Surg 2004;198:53-959
-
(2004)
J Am Coll Surg
, vol.198
, pp. 53-959
-
-
Duxbury, M.S.1
Ito, H.2
Zinner, M.J.3
-
32
-
-
0037388638
-
Small interfering RNAs directed against β-catenin inhibit the in vitro and in vivo growth of colon cancer cells
-
Verma UN, Surabhi RM, Schmaltieg A, et al. Small interfering RNAs directed against beta-catenin inhibit the in vitro and in vivo growth of colon cancer cells. Clin Cancer Res 2003;9:1291-300 (Pubitemid 36418379)
-
(2003)
Clinical Cancer Research
, vol.9
, Issue.4
, pp. 1291-1300
-
-
Verma, U.N.1
Surabhi, R.M.2
Schmaltieg, A.3
Becerra, C.4
Gaynor, R.B.5
-
33
-
-
10744219596
-
Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector
-
DOI 10.1038/sj.embor.embor865
-
van de Wetering M, Oving I, Muncan V, et al. Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector. EMBO Rep 2003;4:609-15 (Pubitemid 36939953)
-
(2003)
EMBO Reports
, vol.4
, Issue.6
, pp. 609-615
-
-
Van De Wetering, M.1
Oving, I.2
Muncan, V.3
Pon Fong, M.T.4
Brantjes, H.5
Van Leenen, D.6
Holstege, F.C.P.7
Brummelkamp, T.R.8
Agami, R.9
Clevers, H.10
-
34
-
-
23844448634
-
Knockdown of c-Myc expression by RNAi inhibits MCF-7 breast tumor cells growth in vitro and in vivo
-
Wang YH, Liu S, Zhang G, et al. Knockdown of c-Myc expression by RNAi inhibits MCF-7 breast tumor cells growth in vitro and in vivo. Breast Cancer Res 2005;7:R220-8
-
(2005)
Breast Cancer Res
, vol.7
-
-
Wang, Y.H.1
Liu, S.2
Zhang, G.3
-
35
-
-
14544275488
-
Reversal of the phenotype by K-rasval12 silencing mediated by adenovirus-delivered siRNA in human pancreatic cancer cell line Panc-1
-
Chen LM, Le HY, Qin RY, et al. Reversal of the phenotype by K-rasval12 silencing mediated by adenovirus-delivered siRNA in human pancreatic cancer cell line Panc-1. World J Gastroenterol 2005;11:831-8
-
(2005)
World J Gastroenterol
, vol.11
, pp. 831-8
-
-
Chen, L.M.1
Qin, H.Y.2
Le, R.Y.3
-
36
-
-
33846946838
-
Small interfering RNAs targeting mutant K-ras inhibit human pancreatic carcinoma cells growth in vitro and in vivo
-
Zhu H, Liang ZY, Ren XY, et al. Small interfering RNAs targeting mutant K-ras inhibit human pancreatic carcinoma cells growth in vitro and in vivo. Cancer Biol Ther 2006;5:1693-8
-
(2006)
Cancer Biol Ther
, vol.5
, pp. 1693-8
-
-
Zhu, H.1
Liang, Z.Y.2
Ren, X.Y.3
-
37
-
-
17144380109
-
Identification of effective siRNA against K-ras in human pancreatic cancer cell line MiaPaCa-2 by siRNA expression cassette
-
Wang W, Wang CY, Dong JH, et al. Identification of effective siRNA against K-ras in human pancreatic cancer cell line MiaPaCa-2 by siRNA expression cassette. World J Gastroenterol 2005;11:2026-31 (Pubitemid 40521006)
-
(2005)
World Journal of Gastroenterology
, vol.11
, Issue.13
, pp. 2026-2031
-
-
Wang, W.1
Wang, C.-Y.2
Dong, J.-H.3
Chen, X.4
Zhang, M.5
Zhao, G.6
-
38
-
-
70349445575
-
C-Raf is associated with disease progression and cell proliferation in a subset of melanomas
-
Jilaveanu LB, Zito CR, Aziz SA, et al. C-Raf is associated with disease progression and cell proliferation in a subset of melanomas. Clin Cancer Res 2009;15:5704-13
-
(2009)
Clin Cancer Res
, vol.15
, pp. 5704-13
-
-
Jilaveanu, L.B.1
Zito, C.R.2
Aziz, S.A.3
-
39
-
-
22344446375
-
RNA interference: A potential strategy for isoform-specific phosphatidylinositol 3-kinase targeted therapy in ovarian cancer
-
Zhang L, Yang N, Liang S, et al. RNA interference: a potential strategy for isoform-specific phosphatidylinositol 3-kinase targeted therapy in ovarian cancer. Cancer Biol Ther 2004;3:1283-9 (Pubitemid 41350967)
-
(2004)
Cancer Biology and Therapy
, vol.3
, Issue.12
, pp. 1283-1289
-
-
Zhang, L.1
Yang, N.2
Liang, S.3
Barchetti, A.4
Vezzani, C.5
Huang, J.6
O'Brien-Jenkins, A.7
Rubin, S.C.8
Coukos, G.9
-
40
-
-
65549117081
-
RNA interference-mediated silencing of the phosphatidylinositol 3-kinase catalytic subunit attenuates growth of human ovarian cancer cells in vitro and in vivo
-
Zhang X, Deng HX, Zhao X, et al. RNA interference-mediated silencing of the phosphatidylinositol 3-kinase catalytic subunit attenuates growth of human ovarian cancer cells in vitro and in vivo. Oncology 2009;77:22-32
-
(2009)
Oncology
, vol.77
, pp. 22-32
-
-
Zhang, X.1
Deng, H.X.2
Zhao, X.3
-
41
-
-
4444346646
-
AKT involvement in cisplatin chemoresistance of human uterine cancer cells
-
DOI 10.1016/j.ygyno.2004.06.023, PII S0090825804004494
-
Gagnon V, Mathieu I, Sexton E, et al. AKT involvement in cisplatin chemoresistance of human uterine cancer cells. Gynecol Oncol 2004;94:785-95 (Pubitemid 39194476)
-
(2004)
Gynecologic Oncology
, vol.94
, Issue.3
, pp. 785-795
-
-
Gagnon, V.1
Mathieu, I.2
Sexton, E.3
Leblanc, K.4
Asselin, E.5
-
42
-
-
22744458796
-
The antiapoptotic effect of fibroblast growth factor-2 is mediated through nuclear factor-κB activation induced via interaction between Akt and IκB kinase-β in breast cancer cells
-
DOI 10.1038/sj.onc.1208713, PII 1208713
-
Vandermoere F, El Yazidi-Belkoura I, Adriaenssens E, et al. The antiapoptotic effect of fibroblast growth factor-2 is mediated through nuclear factor-kappaB activation induced via interaction between Akt and IkappaB kinase-beta in breast cancer cells. Oncogene 2005;24:5482-91 (Pubitemid 43080091)
-
(2005)
Oncogene
, vol.24
, Issue.35
, pp. 5482-5491
-
-
Vandermoere, F.1
Yazidi-Belkoura, I.E.2
Adriaenssens, E.3
Lemoine, J.4
Hondermarck, H.5
-
43
-
-
2542449068
-
Enhanced chemosensitivity to irinotecan by RNA interference-mediated down-regulation of the nuclear factor-κB p65 subunit
-
DOI 10.1158/1078-0432.CCR-03-0366
-
Guo J, Verma UN, Gaynor RB, et al. Enhanced chemosensitivity to irinotecan by RNA interference-mediated downregulation of the nuclear factor-kappaB p65 subunit. Clin Cancer Res 2004;10:3333-41 (Pubitemid 38685438)
-
(2004)
Clinical Cancer Research
, vol.10
, Issue.10
, pp. 3333-3341
-
-
Guo, J.1
Verma, U.N.2
Gaynor, R.B.3
Frenkel, E.P.4
Becerra, C.R.5
-
44
-
-
0038489117
-
Small interfering RNAs expressed from a Pol III promoter suppress the EWS/Fli-1 transcript in an Ewing sarcoma cell line
-
DOI 10.1016/S1525-0016(03)00101-1
-
Dohjima T, Lee NS, Li H, et al. Small interfering RNAs expressed from a Pol III promoter suppress the EWS/Fli-transcript in an Ewing sarcoma cell line. Mol Ther 2003;7:811-16 (Pubitemid 36790258)
-
(2003)
Molecular Therapy
, vol.7
, Issue.6
, pp. 811-816
-
-
Dohjima, T.1
Lee, N.S.2
Li, H.3
Ohno, T.4
Rossi, J.J.5
-
45
-
-
2942622488
-
Targeting of EWS/FLI-1 by RNA interference attenuates the tumor phenotype of Ewing's sarcoma cells in vitro
-
DOI 10.1016/j.orthres.2003.12.008, PII S0736026603003024
-
Chansky HA, Barahmand-Pour F, Mei Q, et al. Targeting of EWS/FLI-1 by RNA interference attenuates the tumor phenotype of Ewing's sarcoma cells in vitro. J Orthop Res 2004;22:910-17 (Pubitemid 38756277)
-
(2004)
Journal of Orthopaedic Research
, vol.22
, Issue.4
, pp. 910-917
-
-
Chansky, H.A.1
Barahmand-pour, F.2
Mei, Q.3
Kahn-Farooqi, W.4
Zielinska-Kwiatkowska, A.5
Blackburn, M.6
Chansky, K.7
Conrad III, E.U.8
Bruckner, J.D.9
Greenlee, T.K.10
Yang, L.11
-
46
-
-
0344671608
-
Functions of the retinoblastoma protein
-
Kaelin WG Jr. Functions of the retinoblastoma protein. Bioessays 1999;21:950-8 (Pubitemid 29530604)
-
(1999)
BioEssays
, vol.21
, Issue.11
, pp. 950-958
-
-
Kaelin Jr., W.G.1
-
47
-
-
0036559896
-
Papillomaviruses and cancer: From basic studies to clinical application
-
Zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002; 2 342-50 (Pubitemid 37328947)
-
(2002)
Nature Reviews Cancer
, vol.2
, Issue.5
, pp. 342-350
-
-
Zur Hausen, H.1
-
48
-
-
0037026601
-
Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference
-
Jiang M, Milner J. Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference. Oncogene 2002;21:6041-8
-
(2002)
Oncogene
, vol.21
, pp. 6041-8
-
-
Jiang, M.1
Milner, J.2
-
49
-
-
3042743989
-
Genotoxic stress induces expression of E2F4, leading to its association with p130 in prostate carcinoma cells
-
DOI 10.1158/0008-5472.CAN-03-3695
-
DuPree EL, Mazumder S, Almasan A. Genotoxic stress induces expression of E2F4, leading to its association with p130 in prostate carcinoma cells. Cancer Res 2004;64:4390-3 (Pubitemid 38856906)
-
(2004)
Cancer Research
, vol.64
, Issue.13
, pp. 4390-4393
-
-
DuPree, E.L.1
Mazumder, S.2
Almasan, A.3
-
50
-
-
33645167401
-
Prospects of RNA interference therapy for cancer
-
Pai SI, Lin YY, Macaes B, et al. Prospects of RNA interference therapy for cancer. Gene Ther 2006;13:464-77
-
(2006)
Gene Ther
, vol.13
, pp. 464-77
-
-
Pai, S.I.1
Lin, Y.Y.2
MacAes, B.3
-
51
-
-
2942738959
-
Amplification of Mdmx (or Mdm4) directly contributes to tumor formation by inhibiting p53 tumor suppressor activity
-
DOI 10.1128/MCB.24.13.5835-5843.2004
-
Danovi D, Meulmeester E, Pasini D, et al. Amplification of Mdmx (or Mdm4) directly contributes to tumor formation by inhibiting p53 tumor suppressor activity. Mol Cell Biol 2004;24:5835-43 (Pubitemid 38787968)
-
(2004)
Molecular and Cellular Biology
, vol.24
, Issue.13
, pp. 5835-5843
-
-
Danovi, D.1
Meulmeester, E.2
Pasini, D.3
Migliorini, D.4
Capra, M.5
Frenk, R.6
De Graaf, P.7
Francoz, S.8
Gasparini, P.9
Gobbi, A.10
Helin, K.11
Pelicci, P.G.12
Jochemsen, A.G.13
Marine, J.-C.14
-
52
-
-
20144387679
-
Expression of Notch-1 and its ligands, Delta-like-1 and Jagged=1, is critical for glioma cell survival and proliferation
-
DOI 10.1158/0008-5472.CAN-04-1890
-
Purow BW, Haque RM, Noel MW, et al. Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation. Cancer Res 2005;65:2353-63 (Pubitemid 40490146)
-
(2005)
Cancer Research
, vol.65
, Issue.6
, pp. 2353-2363
-
-
Purow, B.W.1
Haque, R.M.2
Noel, M.W.3
Su, Q.4
Burdick, M.J.5
Lee, J.6
Sundaresan, T.7
Pastorino, S.8
Park, J.K.9
Mikolaenko, I.10
Maric, D.11
Eberhart, C.G.12
Fine, H.A.13
-
53
-
-
0141730323
-
SiRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells
-
DOI 10.1038/sj.onc.1206894
-
Butz K, Ristriani T, Hengstermann A, et al. siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells. Oncogene 2003;22:5938-45 (Pubitemid 37175872)
-
(2003)
Oncogene
, vol.22
, Issue.38
, pp. 5938-5945
-
-
Butz, K.1
Ristriani, T.2
Hengstermann, A.3
Denk, C.4
Scheffner, M.5
Hoppe-Seyler, F.6
-
54
-
-
4143080409
-
Cyclin B1 depletion inhibits proliferation and induces apoptosis in human tumor cells
-
DOI 10.1038/sj.onc.1207757
-
Yuan J, Yan R, Kramer A, et al. Cyclin B1 depletion inhibits proliferation and induces apoptosis in human tumor cells. Oncogene 2004;23:5843-52 (Pubitemid 39093030)
-
(2004)
Oncogene
, vol.23
, Issue.34
, pp. 5843-5852
-
-
Yuan, J.1
Yan, R.2
Kramer, A.3
Eckerdt, F.4
Roller, M.5
Kaufmann, M.6
Strebhardt, K.7
-
55
-
-
77349095037
-
Differential roles of cyclin D1 and D3 in pancreatic ductal adenocarcinoma
-
Radulovich N, Pham NA, Strumpf D, et al. Differential roles of cyclin D1 and D3 in pancreatic ductal adenocarcinoma. Mol Cancer 2010;9:1-15
-
(2010)
Mol Cancer
, vol.9
, pp. 1-15
-
-
Radulovich, N.1
Pham, N.A.2
Strumpf, D.3
-
56
-
-
70449105984
-
Suppression of cancer cell growth by promoting cyclin D1 degradation
-
Shan J, Zhao W, Gu W. Suppression of cancer cell growth by promoting cyclin D1 degradation. Mol Cell 2009;36:469-76
-
(2009)
Mol Cell
, vol.36
, pp. 469-76
-
-
Shan, J.1
Zhao, W.2
Gu, W.3
-
57
-
-
77953162429
-
Cyclin D3 is dispensable for human diffuse large B-cell lymphoma survival and growth: Evidence for redundancy with cyclin e
-
Gumina MR, Xu C, Chiles TC. Cyclin D3 is dispensable for human diffuse large B-cell lymphoma survival and growth: evidence for redundancy with cyclin E. Cell Cycle 2010;9:820-8
-
(2010)
Cell Cycle
, vol.9
, pp. 820-8
-
-
Gumina, M.R.1
Xu, C.2
Chiles, T.C.3
-
58
-
-
14844315930
-
A novel mechanism of checkpoint abrogation conferred by Chk1 downregulation
-
DOI 10.1038/sj.onc.1208309
-
Xiao Z, Xue J, Sowin TJ, et al. A novel mechanism of checkpoint abrogation conferred by Chk1 downregulation. Oncogene 2005;24:1403-11 (Pubitemid 40343120)
-
(2005)
Oncogene
, vol.24
, Issue.8
, pp. 1403-1411
-
-
Xiao, Z.1
Xue, J.2
Sowin, T.J.3
Rosenberg, S.H.4
Zhang, H.5
-
59
-
-
77951937736
-
The role of c-FLIP(L) in ovarian cancer: Chaperoning tumor cells from immunosurveillance and increasing their invasive potential
-
El-Gazzar A, Wittinger M, Perco P, et al. The role of c-FLIP(L) in ovarian cancer: chaperoning tumor cells from immunosurveillance and increasing their invasive potential. Gynecol Oncol 2010;117:451-9
-
(2010)
Gynecol Oncol
, vol.117
, pp. 451-9
-
-
El-Gazzar, A.1
Wittinger, M.2
Perco, P.3
-
60
-
-
4844220794
-
Possible role of FLICE-like inhibitory protein (FLIP) in chemoresistant ovarian cancer cells in vitro
-
DOI 10.1038/sj.onc.1207925
-
Abedini MR, Qiu Q, Yan X, et al. Possible role of FLICElike inhibitory protein (FLIP) in chemoresistant ovarian cancer cells in vitro. Oncogene 2004;23:6997-7004 (Pubitemid 39319162)
-
(2004)
Oncogene
, vol.23
, Issue.42
, pp. 6997-7004
-
-
Abedini, M.R.1
Qiu, Q.2
Yan, X.3
Tsang, B.K.4
-
61
-
-
77954668084
-
Simultaneous gene silencing of Bcl-2, XIAP and Survivin re-sensitizes pancreatic cancer cells towards apoptosis
-
Ruckert F, Samm N, Lehner AK, et al. Simultaneous gene silencing of Bcl-2, XIAP and Survivin re-sensitizes pancreatic cancer cells towards apoptosis. BMC Cancer 2010;10:379
-
(2010)
BMC Cancer
, vol.10
, pp. 379
-
-
Ruckert, F.1
Samm, N.2
Lehner, A.K.3
-
62
-
-
2342538514
-
Specific downregulation of bcl-2 and xIAP by RNAi enhances the effects of chemotherapeutic agents in MCF-7 human breast cancer cells
-
DOI 10.1038/sj.cgt.7700706
-
Lima RT, Martins LM, Guimaraes JE, et al. Specific downregulation of bcl-2 and xIAP by RNAi enhances the effects of chemotherapeutic agents in MCF-7 human breast cancer cells. Cancer Gene Ther 2004;11:309-16 (Pubitemid 38586086)
-
(2004)
Cancer Gene Therapy
, vol.11
, Issue.5
, pp. 309-316
-
-
Lima, R.T.1
Martins, L.M.2
Guimaraes, J.E.3
Sambade, C.4
Vasconcelos, M.H.5
-
63
-
-
20144387336
-
Bcl-XL small interfering RNA suppresses the proliferation of 5-fluorouracil-resistant human colon cancer cells
-
Zhu H, Guo W, Zhang L, et al. Bcl-XL small interfering RNA suppresses the proliferation of 5-fluorouracil-resistant human colon cancer cells. Mol Cancer Ther 2005;4:451-6 (Pubitemid 40443930)
-
(2005)
Molecular Cancer Therapeutics
, vol.4
, Issue.3
, pp. 451-456
-
-
Zhu, H.1
Guo, W.2
Zhang, L.3
Davis, J.J.4
Teraishi, F.5
Wu, S.6
Cao, X.7
Daniel, J.8
Smythe, W.R.9
Fang, B.10
-
64
-
-
2442663096
-
Mcl-1 mediates tumor necrosis factor-related apoptosis-inducing ligand resistance in human cholangiocarcinoma cells
-
DOI 10.1158/0008-5472.CAN-03-2770
-
Taniai M, Grambihler A, Higuchi H, et al. Mcl-1 mediates tumor necrosis factor-related apoptosis-inducing ligand resistance in human cholangiocarcinoma cells. Cancer Res 2004;64:3517-24 (Pubitemid 38657926)
-
(2004)
Cancer Research
, vol.64
, Issue.10
, pp. 3517-3524
-
-
Taniai, M.1
Grambihler, A.2
Higuchi, H.3
Werneburg, N.4
Bronk, S.F.5
Farrugia, D.J.6
Kaufmann, S.H.7
Gores, G.J.8
-
65
-
-
16644384180
-
SiRNA-mediated down-regulation of survivin inhibits bladder cancer cell growth
-
Ning S, Fuessel S, Kotzsch M, et al. siRNA-mediated down-regulation of survivin inhibits bladder cancer cell growth. Int J Oncol 2004;25:1065-71
-
(2004)
Int J Oncol
, vol.25
, pp. 1065-71
-
-
Ning, S.1
Fuessel, S.2
Kotzsch, M.3
-
66
-
-
10744227367
-
Knockdown of survivin expression by small interfering RNA reduces the clonogenic survival of human sarcoma cell lines independently of p53
-
DOI 10.1038/sj.cgt.7700677
-
Kappler M, Bache M, Bartel F, et al. Knockdown of survivin expression by small interfering RNA reduces the clonogenic survival of human sarcoma cell lines independently of p53. Cancer Gene Ther 2004;11:186-93 (Pubitemid 38280521)
-
(2004)
Cancer Gene Therapy
, vol.11
, Issue.3
, pp. 186-193
-
-
Kappler, M.1
Bache, M.2
Bartel, F.3
Kotzsch, M.4
Panian, M.5
Wurl, P.6
Blumke, K.7
Schmidt, H.8
Meye, A.9
Taubert, H.10
-
67
-
-
3042853830
-
Adenovirus-mediated transfer of siRNA against survivin induced apoptosis and attenuated tumor cell growth in vitro and in vivo
-
DOI 10.1016/j.ymthe.2004.05.006, PII S1525001604001716
-
Uchida H, Tanaka T, Sasaki K, et al. Adenovirus-mediated transfer of siRNA against surviving induced apoptosis and attenuated tumor cell growth in vitro and in vivo. Mol Ther 2004;10:162-71 (Pubitemid 38878158)
-
(2004)
Molecular Therapy
, vol.10
, Issue.1
, pp. 162-171
-
-
Uchida, H.1
Tanaka, T.2
Sasaki, K.3
Kato, K.4
Dehari, H.5
Ito, Y.6
Kobune, M.7
Miyagishi, M.8
Taira, K.9
Tahara, H.10
Hamada, H.11
-
68
-
-
13544273457
-
Knockdown of survivin gene expression by RNAi induces apoptosis in human hepatocellular carcinoma cell line SMMC-7721
-
Cheng SQ, Wang WL, Yan W, et al. Knockdown of survivin gene expression by RNAi induces apoptosis in human hepatocellular carcinoma cell line SMMC-7721. World J Gastroenterol 2005;11:756-9 (Pubitemid 40220775)
-
(2005)
World Journal of Gastroenterology
, vol.11
, Issue.5
, pp. 756-759
-
-
Cheng, S.-Q.1
Wang, W.-L.2
Yan, W.3
Li, Q.-L.4
Wang, L.5
Wang, W.-Y.6
-
69
-
-
3042518905
-
Enhancement of C2-ceramide antitumor activity by small interfering RNA on X chromosome-linked inhibitor of apoptosis protein in resistant human glioma cells
-
Hatano M, Mizuno M, Yoshida J. Enhancement of C2-ceramide antitumor activity by small interfering RNA on X chromosome-linked inhibitor of apoptosis protein in resistant human glioma cells. J Neurosurg 2004;101:119-27 (Pubitemid 38808471)
-
(2004)
Journal of Neurosurgery
, vol.101
, Issue.1
, pp. 119-127
-
-
Hatano, M.1
Mizuno, M.2
Yoshida, J.3
-
70
-
-
4444222462
-
Nucleotide-based therapies targeting clusterin chemosensitize human lung adenocarcinoma cells both in vitro and in vivo
-
July LV, Beraldi E, So A, et al. Nucleotide-based therapies targeting clusterin chemosensitize human lung adenocarcinoma cells both in vitro and in vivo. Mol Cancer Ther 2004;3:223-32 (Pubitemid 39193697)
-
(2004)
Molecular Cancer Therapeutics
, vol.3
, Issue.3
, pp. 223-232
-
-
July, L.V.1
Beraldi, E.2
So, A.3
Fazli, L.4
Evans, K.5
English, J.C.6
Gleave, M.E.7
-
71
-
-
2942597745
-
Functional characterization of hepatoma-specific stem cell antigen-2
-
DOI 10.1002/mc.20019
-
He J, Chang LJ. Functional characterization of hepatomaspecific stem cell antigen-2. Mol Carcinog 2004;40:90-103 (Pubitemid 38736535)
-
(2004)
Molecular Carcinogenesis
, vol.40
, Issue.2
, pp. 90-103
-
-
He, J.1
Chang, L.-J.2
-
72
-
-
2542425324
-
Glycogen synthase kinase-3beta suppression eliminates tumor necrosis factorrelated apoptosis-inducing ligand resistance in prostate cancer
-
Liao X, Zhang L, Thrasher JB, et al. Glycogen synthase kinase-3beta suppression eliminates tumor necrosis factorrelated apoptosis-inducing ligand resistance in prostate cancer. Mol Cancer Ther 2003;2:1215-22
-
(2003)
Mol Cancer Ther
, vol.2
, pp. 1215-22
-
-
Liao, X.1
Zhang, L.2
Thrasher, J.B.3
-
73
-
-
5144220294
-
Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells
-
DOI 10.1158/1078-0432.CCR-04-0576
-
Izeradjene K, Douglas L, Delaney A, Houghton JA. Influence of casein kinase II in tumor necrosis factor-related apoptosis- inducing ligand-induced apoptosis in human rhabdomyosarcoma cells. Clin Cancer Res 2004;10:6650-60 (Pubitemid 39346562)
-
(2004)
Clinical Cancer Research
, vol.10
, Issue.19
, pp. 6650-6660
-
-
Izeradjene, K.1
Douglas, L.2
Delaney, A.3
Houghton, J.A.4
-
74
-
-
34247167211
-
Down-regulation of human telomerase reverse transcriptase through specific activation of RNAi pathway quickly results in cancer cell growth impairment
-
DOI 10.1016/j.bcp.2007.01.035, PII S0006295207000640
-
Gandellini P, Folini M, Bandiera R, et al. Down-regulation of human telomerase reverse transcriptase through specific activation of RNAi pathway quickly results in cancer cell growth impairment. Biochem Pharmacol 2007;73:1703-14 (Pubitemid 46601404)
-
(2007)
Biochemical Pharmacology
, vol.73
, Issue.11
, pp. 1703-1714
-
-
Gandellini, P.1
Folini, M.2
Bandiera, R.3
De Cesare, M.4
Binda, M.5
Veronese, S.6
Daidone, M.G.7
Zunino, F.8
Zaffaroni, N.9
-
75
-
-
22144492967
-
Efficient inhibition of human telomerase reverse transcriptase expression by RNA interference sensitizes cancer cells to ionizing radiation and chemotherapy
-
DOI 10.1089/hum.2005.16.859
-
Nakamura M, Masutomi K, Kyo S, et al. Efficient inhibition of human telomerase reverse transcriptase expression by RNA interference sensitizes cancer cells to ionizing radiation and chemotherapy. Hum Gene Ther 2005;16:859-68 (Pubitemid 40982334)
-
(2005)
Human Gene Therapy
, vol.16
, Issue.7
, pp. 859-868
-
-
Nakamura, M.1
Masutomi, K.2
Kyo, S.3
Hashimoto, M.4
Maida, Y.5
Kanaya, T.6
Tanaka, M.7
Hahn, W.C.8
Inoue, M.9
-
76
-
-
12444305353
-
Telomerase reverse transcriptase (hTERT) mRNA and telomerase RNA (hTR) as targets for downregulation of telomerase activity
-
Natarajan S, Chen Z, Wancewicz EV, et al. Telomerase reverse transcriptase (hTERT) mRNA and telomerase RNA (hTR) as targets for downregulation of telomerase activity. Oligonucleotides 2004;14:263-73 (Pubitemid 40144364)
-
(2004)
Oligonucleotides
, vol.14
, Issue.4
, pp. 263-273
-
-
Natarajan, S.1
Chen, Z.2
Wancewicz, E.V.3
Monia, B.P.4
Corey, D.R.5
-
77
-
-
0037308546
-
Simultaneous targeting of telomeres and telomerase as a cancer therapeutic approach
-
Mo Y, Gan Y, Song S, et al. Simultaneous targeting of telomeres and telomerase as a cancer therapeutic approach. Cancer Res 2003;63:579-85 (Pubitemid 36158134)
-
(2003)
Cancer Research
, vol.63
, Issue.3
, pp. 579-585
-
-
Mo, Y.1
Gan, Y.2
Song, S.3
Johnston, J.4
Xiao, X.5
Wientjes, M.G.6
Au, J.L.-S.7
-
78
-
-
33748537714
-
Telomerase inhibition by an siRNA directed against hTERT leads to telomere attrition in HT29 cells
-
de Souza Nascimento P, Alves G, Fiedler W. Telomerase inhibition by an siRNA directed against hTERT leads to telomere attrition in HT29 cells. Oncol Rep 2006;16:423-8
-
(2006)
Oncol Rep
, vol.16
, pp. 423-8
-
-
De Souza Nascimento, P.1
Alves, G.2
Fiedler, W.3
-
79
-
-
32444445166
-
RNAi-hTERT inhibition hepatocellular carcinoma cell proliferation via decreasing telomerase activity
-
DOI 10.1016/j.jss.2005.09.017, PII S0022480405005007
-
Zhang PH, Zou L, Tu ZG. RNAi-hTERT inhibition hepatocellular carcinoma cell proliferation via decreasing telomerase activity. J Surg Res 2006;131:143-9 (Pubitemid 43227598)
-
(2006)
Journal of Surgical Research
, vol.131
, Issue.1
, pp. 143-149
-
-
Zhang, P.-H.1
Zou, L.2
Tu, Z.-G.3
-
80
-
-
67649764432
-
SiRNA inhibition of telomerase enhances the anti-cancer effect of doxorubicin in breast cancer cells
-
Dong X, Liu A, Zer C, et al. siRNA inhibition of telomerase enhances the anti-cancer effect of doxorubicin in breast cancer cells. BMC Cancer 2009;9:1-10
-
(2009)
BMC Cancer
, vol.9
, pp. 1-10
-
-
Dong, X.1
Liu, A.2
Zer, C.3
-
81
-
-
0345275873
-
Small Interfering RNA-Mediated Reduction in Heterogeneous Nuclear Ribonucleoparticule A1/A2 Proteins Induces Apoptosis in Human Cancer Cells but not in Normal Mortal Cell Lines
-
Patry C, Bouchard L, Labrecque P, et al. Small interfering RNA-mediated reduction in heterogeneous nuclear ribonucleoparticule A1/A2 proteins induces apoptosis in human cancer cells but not in normal mortal cell lines. Cancer Res 2003;63:7679-88 (Pubitemid 37466696)
-
(2003)
Cancer Research
, vol.63
, Issue.22
, pp. 7679-7688
-
-
Patry, C.1
Bouchard, L.2
Labrecque, P.3
Gendron, D.4
Lemieux, B.5
Toutant, J.6
Lapointe, E.7
Wellinger, R.8
Chabot, B.9
-
82
-
-
2442668068
-
A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics
-
DOI 10.1158/0008-5472.CAN-03-2682
-
Takei Y, Kadomatsu K, Yuzawa Y, et al. A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics. Cancer Res 2004;64:3365-70 (Pubitemid 38657905)
-
(2004)
Cancer Research
, vol.64
, Issue.10
, pp. 3365-3370
-
-
Takei, Y.1
Kadomatsu, K.2
Yuzawa, Y.3
Matsuo, S.4
Muramatsu, T.5
-
83
-
-
78449270531
-
Vascular endothelial growth factor-C promotes the growth and invasion of gallbladder cancer via an autocrine mechanism
-
Chen Y, Jiang L, She F, et al. Vascular endothelial growth factor-C promotes the growth and invasion of gallbladder cancer via an autocrine mechanism. Mol Cell Biochem 2010;345:77-89
-
(2010)
Mol Cell Biochem
, vol.345
, pp. 77-89
-
-
Chen, Y.1
Jiang, L.2
She, F.3
-
84
-
-
77949461468
-
Blocking effects of siRNA on VEGF expression in human colorectal cancer cells
-
Yin Y, Cao LY, Wu WQ, et al. Blocking effects of siRNA on VEGF expression in human colorectal cancer cells. World J Gastroenterol 2010;16:1086-92
-
(2010)
World J Gastroenterol
, vol.16
, pp. 1086-92
-
-
Yin, Y.1
Cao, L.Y.2
Wu, W.Q.3
-
85
-
-
14544298301
-
Cancer siRNA therapy by tumor selective delivery with ligandtargeted sterically stabilized nanoparticle
-
Schiffelers RM, Ansari A, Xu J, et al. Cancer siRNA therapy by tumor selective delivery with ligandtargeted sterically stabilized nanoparticle. Nucleic Acids Res 2004;32:1-10
-
(2004)
Nucleic Acids Res
, vol.32
, pp. 1-10
-
-
Schiffelers, R.M.1
Ansari, A.2
Xu, J.3
-
86
-
-
70549112947
-
Inhibiting tumor growth of colorectal cancer by blocking the expression of vascular endothelial growth factor receptor 3 using interference vector-based RNA interference
-
Lui Z, Ma Q, Wang X, et al. Inhibiting tumor growth of colorectal cancer by blocking the expression of vascular endothelial growth factor receptor 3 using interference vector-based RNA interference. Int J Mol Med 2010;25:59-64
-
(2010)
Int J Mol Med
, vol.25
, pp. 59-64
-
-
Lui, Z.1
Ma, Q.2
Wang, X.3
-
87
-
-
4444233040
-
Small interfering RNA urokinase silencing inhibits invasion and migration of human hepatocellular carcinoma cells
-
Salvi A, Arici B, De Petro G, et al. Small interfering RNA urokinase silencing inhibits invasion and migration of human hepatocellular carcinoma cells. Mol Cancer Ther 2004;3:671-8 (Pubitemid 39193747)
-
(2004)
Molecular Cancer Therapeutics
, vol.3
, Issue.6
, pp. 671-678
-
-
Salvi, A.1
Arici, B.2
De Petro, G.3
Barlati, S.4
-
88
-
-
77954812525
-
Inhibition of human breast cancer cell invasion by siRNA against urokinase-type plasminogen activator
-
Huang HY, Jiang ZF, Li QX, et al. Inhibition of human breast cancer cell invasion by siRNA against urokinase-type plasminogen activator. Cancer Invest 2010;28:689-97
-
(2010)
Cancer Invest
, vol.28
, pp. 689-97
-
-
Huang, H.Y.1
Jiang, Z.F.2
Li, Q.X.3
-
89
-
-
64549083733
-
Therapeutic potential of siRNA-mediated targeting of urokinase plasminogen activator, its receptor, and matrix metalloproteinases
-
Gondi CS, Rao JS. Therapeutic potential of siRNA-mediated targeting of urokinase plasminogen activator, its receptor, and matrix metalloproteinases. Methods Mol Biol 2009;487:267-81
-
(2009)
Methods Mol Biol
, vol.487
, pp. 267-81
-
-
Gondi, C.S.1
Rao, J.S.2
-
90
-
-
9144231998
-
RNAi-mediated inhibition of cathepsin B and uPAR leads to decreased cell invasion, angiogenesis and tumor growth in gliomas
-
DOI 10.1038/sj.onc.1207879
-
Gondi CS, Lakka SS, Dinh DH, et al. RNAi-mediated inhibition of cathepsin B and uPAR leads to decreased cell invasion, angiogenesis and tumor growth in gliomas. Oncogene 2004;23:8486-96 (Pubitemid 39540799)
-
(2004)
Oncogene
, vol.23
, Issue.52
, pp. 8486-8496
-
-
Gondi, C.S.1
Lakka, S.S.2
Dinh, D.H.3
Olivero, W.C.4
Gujrati, M.5
Rao, J.S.6
-
91
-
-
77955920079
-
Targeting MMP-9, uPAR, and cathepsin B inhibits invasion, migration and activates apoptosis in prostate cancer cells
-
Nalla AK, Gorantla B, Gondi CS, et al. Targeting MMP-9, uPAR, and cathepsin B inhibits invasion, migration and activates apoptosis in prostate cancer cells. Cancer Gene Ther 2010;17:599-613
-
(2010)
Cancer Gene Ther
, vol.17
, pp. 599-613
-
-
Nalla, A.K.1
Gorantla, B.2
Gondi, C.S.3
-
92
-
-
20444470108
-
Specific interference of urokinase-type plasminogen activator receptor and matrix metalloproteinase-9 gene expression induced by double-stranded RNA results in decreased invasion, tumor growth, and angiogenesis in gliomas
-
DOI 10.1074/jbc.M408520200
-
Lakka SS, Gondi CS, Dinh DH, et al. Specific interference of uPAR and MMP-9 gene expression induced by double-stranded RNA results in decreased invasion, tumor growth and angiogenesis in gliomas. J Biol Chem 2005;280:21882-92 (Pubitemid 40827839)
-
(2005)
Journal of Biological Chemistry
, vol.280
, Issue.23
, pp. 21882-21892
-
-
Lakka, S.S.1
Gondi, C.S.2
Dinh, D.H.3
Olivero, W.C.4
Gujrati, M.5
Rao, V.H.6
Sioka, C.7
Rao, J.S.8
-
93
-
-
4644254026
-
Reversal of the malignant phenotype of gastric cancer cells by inhibition of RhoA expression and activity
-
DOI 10.1158/1078-0432.CCR-04-0242
-
Liu N, Bi F, Pan Y, et al. Reversal of the malignant phenotype of gastric cancer cells by inhibition of RhoA expression and activity. Clin Cancer Res 2004;10:6239-47 (Pubitemid 39287532)
-
(2004)
Clinical Cancer Research
, vol.10
, Issue.18
, pp. 6239-6247
-
-
Liu, N.1
Bi, F.2
Pan, Y.3
Sun, L.4
Xue, V.5
Shi, Y.6
Yao, X.7
Zheng, Y.8
Fan, D.9
-
94
-
-
77952709202
-
Characterization of the roles of RHOC and RHOA GTPases in invasion, motility, and matrix adhesion in inflammatory and aggressive breast cancers
-
Wu M, Wu ZF, Rosenthal DT, et al. Characterization of the roles of RHOC and RHOA GTPases in invasion, motility, and matrix adhesion in inflammatory and aggressive breast cancers. Cancer 2010;116:2768-82
-
(2010)
Cancer
, vol.116
, pp. 2768-82
-
-
Wu, M.1
Wu, Z.F.2
Rosenthal, D.T.3
-
95
-
-
0042941765
-
Down-regulation of CXCR4 by inducible small interfering RNA inhibits breast cancer cell invasion in vitro
-
Chen Y, Stamatoyannopoulos G, Song CZ. Down-regulation of CXCR4 by inducible small interfering RNA inhibits breast cancer cell invasion in vitro. Cancer Res 2003;63:4801-4 (Pubitemid 37022609)
-
(2003)
Cancer Research
, vol.63
, Issue.16
, pp. 4801-4804
-
-
Chen, Y.1
Stamatoyannopoulos, G.2
Song, C.-Z.3
-
96
-
-
73349084970
-
Inhibition of chemokine receptor expression on uveal melanomas by CXCR4 siRNA and its effect on uveal melanoma liver metastases
-
Li H, Yang W, Chen PW, et al. Inhibition of chemokine receptor expression on uveal melanomas by CXCR4 siRNA and its effect on uveal melanoma liver metastases. Invest Ophthalmol Vis Sci 2009;50:5522-8
-
(2009)
Invest Ophthalmol Vis Sci
, vol.50
, pp. 5522-8
-
-
Li, H.1
Yang, W.2
Chen, P.W.3
-
97
-
-
13644262451
-
Insulin-like growth factor binding protein 2 promotes ovarian cancer cell invasion
-
Lee EJ, Mircean C, Shmulevich I, et al. Insulin-like growth factor binding protein 2 promotes ovarian cancer cell invasion. Mol Cancer 2005;4:1-8
-
(2005)
Mol Cancer
, vol.4
, pp. 1-8
-
-
Lee, E.J.1
Mircean, C.2
Shmulevich, I.3
-
98
-
-
0142061975
-
Use of RNA interference to inhibit integrin (α6β4)-mediated invasion and migration of breast carcinoma cells
-
DOI 10.1023/A:1025819521707
-
Lipscomb EA, Dugan AS, Rabinovitz I, et al. Use of RNA interference to inhibit integrin (alpha6beta4)-mediated invasion and migration of breast carcinoma cells. Clin Exp Metastasis 2003;20:569-76 (Pubitemid 37297186)
-
(2003)
Clinical and Experimental Metastasis
, vol.20
, Issue.6
, pp. 569-576
-
-
Lipscomb, E.A.1
Dugan, A.S.2
Rabinovitz, I.3
Mercurio, A.M.4
-
99
-
-
4143074922
-
EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy
-
DOI 10.1158/0008-5472.CAN-04-0754
-
Osta WA, Chen Y, Mikhitarian K, et al. EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy. Cancer Res 2004;64:5818-24 (Pubitemid 39095582)
-
(2004)
Cancer Research
, vol.64
, Issue.16
, pp. 5818-5824
-
-
Osta, W.A.1
Chen, Y.2
Mikhitarian, K.3
Mitas, M.4
Salem, M.5
Hannun, Y.A.6
Cole, D.J.7
Gillanders, W.E.8
-
100
-
-
78649605959
-
Cationic polymer-mediated small interfering RNA delivery for P-glycoprotein down-regulation in tumor cells
-
Abbasi M, Lavasanifar A, Berthiaume LG, et al. Cationic polymer-mediated small interfering RNA delivery for P-glycoprotein down-regulation in tumor cells. Cancer 2010;116:5544-54
-
(2010)
Cancer
, vol.116
, pp. 5544-54
-
-
Abbasi, M.1
Lavasanifar, A.2
Berthiaume, L.G.3
-
101
-
-
77956544799
-
Inhibition of ABCB1 (MDR1) expression by an siRNA nanoparticulate delivery system to overcome drug resistance in osteosarcoma
-
2010
-
Susa M, Iyer AK, Ryu K, et al. Inhibition of ABCB1 (MDR1) expression by an siRNA nanoparticulate delivery system to overcome drug resistance in osteosarcoma. PLoS One 2010;5:e10764
-
PLoS One
, vol.5
-
-
Susa, M.1
Iyer, A.K.2
Ryu, K.3
-
102
-
-
77952025485
-
The siRNA targeted to mdr1b and mdr1a mRNAs in vivo sensitizes murine lymphosarcoma to chemotherapy
-
Patutina OA, Mironova NL, Popova NA, et al. The siRNA targeted to mdr1b and mdr1a mRNAs in vivo sensitizes murine lymphosarcoma to chemotherapy. BMC Cancer 2010;10:1-11
-
(2010)
BMC Cancer
, vol.10
, pp. 1-11
-
-
Patutina, O.A.1
Mironova, N.L.2
Popova, N.A.3
-
103
-
-
77953048951
-
Virus-mimetic polymeric micelles for targeted siRNA delivery
-
Xiong XB, Uludag H, Lavasanifar A. Virus-mimetic polymeric micelles for targeted siRNA delivery. Biomaterials 2010;31:5886-93
-
(2010)
Biomaterials
, vol.31
, pp. 5886-93
-
-
Xiong, X.B.1
Uludag, H.2
Lavasanifar, A.3
-
104
-
-
77954599597
-
Multifunctional nanoparticles delivering small interfering RNA and doxorubicin overcome drug resistance in cancer
-
Chen Y, Bathula SR, Li J, et al. Multifunctional nanoparticles delivering small interfering RNA and doxorubicin overcome drug resistance in cancer. J Biol Chem 2010;285:22639-50
-
(2010)
J Biol Chem
, vol.285
, pp. 22639-50
-
-
Chen, Y.1
Bathula, S.R.2
Li, J.3
-
105
-
-
4444275386
-
Inhibition of ABCB1 (MDR1) and ABCB4 (MDR3) expression by small interfering RNA and reversal resistance in human ovarian cancer cells
-
Duan Z, Brakora KA, Seiden MV. Inhibition of ABCB1 (MDR1) and ABCB4 (MDR3) expression by small interfering RNA and reversal of paclitaxel resistance in human ovarian cancer cells. Mol Cancer Ther 2004;3(7):833-8 (Pubitemid 39193765)
-
(2004)
Molecular Cancer Therapeutics
, vol.3
, Issue.7
, pp. 833-838
-
-
Duan, Z.1
Brakora, K.A.2
Seiden, M.V.3
-
106
-
-
3042655528
-
Membrane transporters and channels: Role of the transportome in cancer chemosensitivity and chemoresistance
-
DOI 10.1158/0008-5472.CAN-03-3884
-
Huang Y, Anderle P, Bussey KJ, et al. Membrane transporters and channels: role of the transportome in cancer chemosensitivity and chemoresistance. Cancer Res 2004;64:4294-301 (Pubitemid 38802436)
-
(2004)
Cancer Research
, vol.64
, Issue.12
, pp. 4294-4301
-
-
Huang, Y.1
Anderle, P.2
Bussey, K.J.3
Barbacioru, C.4
Shankavaram, U.5
Dai, Z.6
Reinhold, W.C.7
Papp, A.8
Weinstein, J.N.9
Sadee, W.10
-
107
-
-
11844302173
-
SiRNA therapeutics: Big potential from small RNAs
-
DOI 10.1038/sj.gt.3302356
-
Ryther RC, Flynt AS, Phillips JA III, et al. siRNA therapeutics: big potential from small RNAs. Gene Ther 2005;12:5-11 (Pubitemid 40090039)
-
(2005)
Gene Therapy
, vol.12
, Issue.1
, pp. 5-11
-
-
Ryther, R.C.C.1
Flynt, A.S.2
Phillips III, J.A.3
Patton, J.G.4
-
108
-
-
33746070441
-
Intravenously administered short interfering RNA accumulates in the kidney and selectively suppresses gene function in renal proximal tubules
-
DOI 10.1124/dmd.106.009555
-
van de Water FM, Boerman OC, Wouterse AC, et al. Intravenously administered short interfering RNA accumulates in the kidney and selectively suppresses gene function in renal proximal tubules. Drug Metab Dispos 2006;34:1393-7 (Pubitemid 44079881)
-
(2006)
Drug Metabolism and Disposition
, vol.34
, Issue.8
, pp. 1393-1397
-
-
Van De Water, F.M.1
Boerman, O.C.2
Wouterse, A.C.3
Peters, J.G.P.4
Russel, F.G.M.5
Masereeuw, R.6
-
109
-
-
0041331496
-
SiRNA function in RNAi: A chemical modification analysis
-
DOI 10.1261/rna.5103703
-
Chiu YL, Rana TM. siRNA function in RNAi: a chemical modification analysis. RNA 2003;9:1034-48 (Pubitemid 37093614)
-
(2003)
RNA
, vol.9
, Issue.9
, pp. 1034-1048
-
-
Chiu, Y.-L.1
Rana, T.M.2
-
110
-
-
24344500241
-
Sequence, chemical, and structural variation of small interfering RNAs and short hairpin RNAs and the effect on mammalian gene silencing
-
Harborth J, Elbashir SM, Vandenburgh K, et al. Sequence, chemical, and structural variation of small interfering RNAs and short hairpin RNAs and the effect on mammalian gene silencing. Antisense Nucleic Acid Drug Dev 2003;13:83-105
-
(2003)
Antisense Nucleic Acid Drug Dev
, vol.13
, pp. 83-105
-
-
Harborth, J.1
Elbashir, S.M.2
Vandenburgh, K.3
-
111
-
-
0038606999
-
Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells
-
DOI 10.1093/nar/gkg393
-
Czauderna F, Fechtner M, Dames S, et al. Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells. Nucleic Acids Res 2003;31:2705-16 (Pubitemid 37442115)
-
(2003)
Nucleic Acids Research
, vol.31
, Issue.11
, pp. 2705-2716
-
-
Czauderna, F.1
Fechtner, M.2
Dames, S.3
Aygun, H.4
Klippel, A.5
Pronk, G.J.6
Giese, K.7
Kaufmann, J.8
-
112
-
-
0038385504
-
RNA interference in mammalian cells by chemically-modified RNA
-
DOI 10.1021/bi0343774
-
Braasch DA, Jensen S, Liu Y, et al. RNA interference in mammalian cells by chemically modified RNA. Biochemistry 2003;42:7967-75 (Pubitemid 36807714)
-
(2003)
Biochemistry
, vol.42
, Issue.26
, pp. 7967-7975
-
-
Braasch, D.A.1
Jensen, S.2
Liu, Y.3
Kaur, K.4
Arar, K.5
White, M.A.6
Corey, D.R.7
-
113
-
-
1942533474
-
In vivo activity of nuclease-resistant siRNAs
-
DOI 10.1261/rna.5239604
-
Layzer JM, McCaffrey AP, Tanner AK, et al. In vivo activity of nuclease-resistant siRNAs. RNA 2004;10:766-71 (Pubitemid 38529739)
-
(2004)
RNA
, vol.10
, Issue.5
, pp. 766-771
-
-
Layzer, J.M.1
McCaffrey, A.P.2
Tanner, A.K.3
Huang, Z.4
Kay, M.A.5
Sullenger, B.A.6
-
114
-
-
11344257391
-
RNA interference using boranophosphate siRNAs: Structure-activity relationships
-
DOI 10.1093/nar/gkh936
-
Hall AH, Wan J, Shaughnessy EE, et al. RNA interference using boranophosphate siRNAs: structure-activity relationships. Nucleic Acids Res 2004;32:5991-6000 (Pubitemid 40073994)
-
(2004)
Nucleic Acids Research
, vol.32
, Issue.20
, pp. 5991-6000
-
-
Hall, A.H.S.1
Wan, J.2
Shaughnessy, E.E.3
Shaw, B.R.4
Alexander, K.A.5
-
115
-
-
33645550066
-
RNAi: A novel antisense technology and its therapeutic potential
-
Dallas A, Vlassov AV. RNAi: a novel antisense technology and its therapeutic potential. Med Sci Monit 2006;12:RA67-74
-
(2006)
Med Sci Monit
, vol.12
-
-
Dallas, A.1
Vlassov, A.V.2
-
116
-
-
23444445660
-
Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs
-
DOI 10.1038/nbt1122
-
Morrissey DV, Lockridge JA, Shaw L, et al. Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs. Nat Biotechnol 2005;23:1002-7 (Pubitemid 41114035)
-
(2005)
Nature Biotechnology
, vol.23
, Issue.8
, pp. 1002-1007
-
-
Morrissey, D.V.1
Lockridge, J.A.2
Shaw, L.3
Blanchard, K.4
Jensen, K.5
Breen, W.6
Hartsough, K.7
Machemer, L.8
Radka, S.9
Jadhav, V.10
Vaish, N.11
Zinnen, S.12
Vargeese, C.13
Bowman, K.14
Shaffer, C.S.15
Jeffs, L.B.16
Judge, A.17
MacLachlan, I.18
Polisky, B.19
-
117
-
-
65649085603
-
Confirming the RNAi-mediated mechanism of action of siRNA-based cancer therapeutics in mice
-
Judge AD, Robbins M, Tavakoli I, et al. Confirming the RNAi-mediated mechanism of action of siRNA-based cancer therapeutics in mice. J Clin Invest 2009;119:661-73
-
(2009)
J Clin Invest
, vol.119
, pp. 661-73
-
-
Judge, A.D.1
Robbins, M.2
Tavakoli, I.3
-
118
-
-
60049089373
-
Development of a novel method for formulating stable siRNA-loaded lipid particles for in vivo use
-
Wu SY, Putral LN, Liang M, et al. Development of a novel method for formulating stable siRNA-loaded lipid particles for in vivo use. Pharm Res 2009;26:512-22
-
(2009)
Pharm Res
, vol.26
, pp. 512-22
-
-
Wu, S.Y.1
Putral, L.N.2
Liang, M.3
-
119
-
-
78650997059
-
Systemic delivery of E6/7 siRNA using novel lipidic particles and its application with cisplatin in cervical cancer mouse models
-
Wu SY, Singhania A, Burgess M, et al. Systemic delivery of E6/7 siRNA using novel lipidic particles and its application with cisplatin in cervical cancer mouse models. Gene Ther 2010;18:14-22
-
(2010)
Gene Ther
, vol.18
, pp. 14-22
-
-
Wu, S.Y.1
Singhania, A.2
Burgess, M.3
-
120
-
-
77950516882
-
Nanoparticles targeted with NGR motif deliver c-myc siRNA and doxorubicin for anticancer therapy
-
Chen Y, Wu JJ, Huang L. Nanoparticles targeted with NGR motif deliver c-myc siRNA and doxorubicin for anticancer therapy. Mol Ther 2010;18:828-34
-
(2010)
Mol Ther
, vol.18
, pp. 828-34
-
-
Chen, Y.1
Wu, J.J.2
Huang, L.3
-
121
-
-
37549004351
-
Tumor-targeted delivery of siRNA by self-assembled nanoparticles
-
Li SD, Chen YC, Hackett MJ, et al. Tumor-targeted delivery of siRNA by self-assembled nanoparticles. Mol Ther 2008;16:163-9
-
(2008)
Mol Ther
, vol.16
, pp. 163-9
-
-
Li, S.D.1
Chen, Y.C.2
Hackett, M.J.3
-
122
-
-
23044506285
-
Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery
-
DOI 10.1158/0008-5472.CAN-05-0530
-
Landen CN Jr, Chavez-Reyes A, Bucana C, et al. Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery. Cancer Res 2005;65:6910-18 (Pubitemid 41060730)
-
(2005)
Cancer Research
, vol.65
, Issue.15
, pp. 6910-6918
-
-
Landen Jr., C.N.1
Chavez-Reyes, A.2
Bucana, C.3
Schmandt, R.4
Deavers, M.T.5
Lopez-Berestein, G.6
Sood, A.K.7
-
123
-
-
33748364149
-
Focal adhesion kinasetargeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy
-
DOI 10.1158/1078-0432.CCR-06-0021
-
Halder J, Kamat AA, Landen CN Jr, et al. Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy. Clin Cancer Res 2006;12:4916-24 (Pubitemid 44338579)
-
(2006)
Clinical Cancer Research
, vol.12
, Issue.16
, pp. 4916-4924
-
-
Halder, J.1
Kamat, A.A.2
Landen Jr., C.N.3
Han, L.Y.4
Lutgendorf, S.K.5
Lin, Y.G.6
Merritt, W.M.7
Jennings, N.B.8
Chavez-Reyes, A.9
Coleman, R.L.10
Gershenson, D.M.11
Schmandt, R.12
Cole, S.W.13
Lopez-Berestein, G.14
Sood, A.K.15
-
124
-
-
68049144915
-
Dual targeting of EphA2 and FAK in ovarian carcinoma
-
Shahzad MM, Lu C, Lee JW, et al. Dual targeting of EphA2 and FAK in ovarian carcinoma. Cancer Biol Ther 2009;8:1027-34
-
(2009)
Cancer Biol Ther
, vol.8
, pp. 1027-34
-
-
Shahzad, M.M.1
Lu, C.2
Lee, J.W.3
-
125
-
-
40949126550
-
Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth
-
DOI 10.1093/jnci/djn024
-
Merritt WM, Lin YG, Spannuth WA, et al. Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth. Natl Cancer Inst 2008;100:359-72 (Pubitemid 351480526)
-
(2008)
Journal of the National Cancer Institute
, vol.100
, Issue.5
, pp. 359-372
-
-
Merritt, W.M.1
Lin, Y.G.2
Spannuth, W.A.3
Fletcher, M.S.4
Kamat, A.A.5
Han, L.Y.6
Landen, C.N.7
Jennings, N.8
De Geest, K.9
Langley, R.R.10
Villares, G.11
Sanguino, A.12
Lutgendorf, S.K.13
Lopez-Berestein, G.14
Bar-Eli, M.M.15
Sood, A.K.16
-
126
-
-
9344224580
-
Antitumor activity of small interfering RNA/cationic liposome complex in mouse models of cancer
-
DOI 10.1158/1078-0432.CCR-04-1049
-
Yano J, Hirabayashi K, Nakagawa S, et al. Antitumor activity of small interfering RNA/cationic liposome complex in mouse models of cancer. Clin Cancer Res 2004;10:7721-6 (Pubitemid 39557537)
-
(2004)
Clinical Cancer Research
, vol.10
, Issue.22
, pp. 7721-7726
-
-
Yano, J.1
Hirabayashi, K.2
Nakagawa, S.-I.3
Yamaguchi, T.4
Nogawa, M.5
Kashimori, I.6
Naito, H.7
Kitagawa, H.8
Ishiyama, K.9
Ohgi, T.10
Irimura, T.11
-
127
-
-
43549096942
-
Anticancer activity of RecQL1 helicase siRNA in mouse xenograft models
-
DOI 10.1111/j.1349-7006.2008.00794.x
-
Futami K, Kumagai E, Makino H, et al. Anticancer activity of RecQL1 helicase siRNA in mouse xenograft models. Cancer Sci 2008;99:1227-36 (Pubitemid 351676636)
-
(2008)
Cancer Science
, vol.99
, Issue.6
, pp. 1227-1236
-
-
Futami, K.1
Kumagai, E.2
Makino, H.3
Sato, A.4
Takagi, M.5
Shimamoto, A.6
Furuichi, Y.7
-
128
-
-
22644439250
-
Systemic delivery of RafsiRNA using cationic cardiolipin liposomes silences Raf-1 expression and inhibits tumor growth in xenograft model of human prostate cancer
-
Pal A, Ahmad A, Khan S, et al. Systemic delivery of RafsiRNA using cationic cardiolipin liposomes silences Raf-1 expression and inhibits tumor growth in xenograft model of human prostate cancer. Int J Oncol 2005;26:1087-91
-
(2005)
Int J Oncol
, vol.26
, pp. 1087-91
-
-
Pal, A.1
Ahmad, A.2
Khan, S.3
-
129
-
-
25144501954
-
Targeting ECM-integrin interaction with liposome-encapsulated small interfering RNAs inhibits the growth of human prostate cancer in a bone xenograft imaging model
-
DOI 10.1016/j.ymthe.2005.05.012, PII S1525001605002807
-
Bisanz K, Yu J, Edlund M, et al. Targeting ECM-integrin interaction with liposome-encapsulated small interfering RNAs inhibits the growth of human prostate cancer in a bone xenograft imaging model. Mol Ther 2005;12:634-43 (Pubitemid 41350144)
-
(2005)
Molecular Therapy
, vol.12
, Issue.4
, pp. 634-643
-
-
Bisanz, K.1
Yu, J.2
Edlund, M.3
Spohn, B.4
Hung, M.-C.5
Chung, L.W.K.6
Hsieh, C.-L.7
-
130
-
-
33748331337
-
RNA interference in the mouse vascular endothelium by systemic administration of siRNA-lipoplexes for cancer therapy
-
DOI 10.1038/sj.gt.3302778, PII 3302778
-
Santel A, Aleku M, Keil O, et al. RNA interference in the mouse vascular endothelium by systemic administration of siRNA-lipoplexes for cancer therapy. Gene Ther 2006;13:1360-70 (Pubitemid 44323692)
-
(2006)
Gene Therapy
, vol.13
, Issue.18
, pp. 1360-1370
-
-
Santel, A.1
Aleku, M.2
Keil, O.3
Endruschat, J.4
Esche, V.5
Durieux, B.6
Loffler, K.7
Fechtner, M.8
Rohl, T.9
Fisch, G.10
Dames, S.11
Arnold, W.12
Giese, K.13
Klippel, A.14
Kaufmann, J.15
-
131
-
-
54949125913
-
Folate-linked lipidbased nanoparticles for synthetic siRNA delivery in KB tumor xenografts
-
Yoshizawa T, Hattori Y, Hakoshima M, et al. Folate-linked lipidbased nanoparticles for synthetic siRNA delivery in KB tumor xenografts. Eur J Pharm Biopharm 2008;70:718-25
-
(2008)
Eur J Pharm Biopharm
, vol.70
, pp. 718-25
-
-
Yoshizawa, T.1
Hattori, Y.2
Hakoshima, M.3
-
132
-
-
33746786005
-
Chemically modified short interfering hybrids (siHybrids): Nanoimmunoliposome delivery in vitro and in vivo for RNAi of HER-2
-
DOI 10.1080/15257770600793885, PII X81X35042T2M0805
-
Hogrefe RI, Lebedev AV, Zon G, et al. Chemically modified short interfering hybrids (siHYBRIDS): nanoimmunoliposome delivery in vitro and in vivo for RNAi of HER-2. Nucleosides Nucleotides Nucleic Acids 2006;25:889-907 (Pubitemid 44180035)
-
(2006)
Nucleosides, Nucleotides and Nucleic Acids
, vol.25
, Issue.8
, pp. 889-907
-
-
Hogrefe, R.1
Lebedev, A.2
Zon, G.3
Pirollo, K.4
Rait, A.5
Zhou, Q.6
Yu, W.7
Chang, E.8
-
133
-
-
30744457637
-
Tumor-targeting nanoimmunoliposome complex for short interfering RNA delivery
-
DOI 10.1089/hum.2006.17.117
-
Pirollo KF, Zon G, Rait A, et al. Tumor-targeting nanoimmunoliposome complex for short interfering RNA delivery. Hum Gene Ther 2006;17:117-24 (Pubitemid 43100520)
-
(2006)
Human Gene Therapy
, vol.17
, Issue.1
, pp. 117-124
-
-
Pirollo, K.F.1
Zon, G.2
Rait, A.3
Zhou, Q.4
Yu, W.5
Hogrefe, R.6
Chang, E.H.7
-
134
-
-
34248228071
-
Materializing the potential of small interfering RNA via a tumor-targeting nanodelivery system
-
DOI 10.1158/0008-5472.CAN-06-4535
-
Pirollo KF, Rait A, Zhou Q, et al. Materializing the potential of small interfering RNA via a tumor-targeting nanodelivery system. Cancer Res 2007;67:2938-43 (Pubitemid 46724828)
-
(2007)
Cancer Research
, vol.67
, Issue.7
, pp. 2938-2943
-
-
Pirollo, K.F.1
Rait, A.2
Zhou, Q.3
Sung, H.H.4
Dagata, J.A.5
Zon, G.6
Hogrefe, R.I.7
Palchik, G.8
Chang, E.H.9
-
135
-
-
33750008791
-
The transferrin receptor part I: Biology and targeting with cytotoxic antibodies for the treatment of cancer
-
DOI 10.1016/j.clim.2006.06.010, PII S1521661606007807
-
Daniels TR, Delgado T, Rodriguez JA, et al. The transferrin receptor part I: biology and targeting with cytotoxic antibodies for the treatment of cancer. Clin Immunol 2006;121:144-58 (Pubitemid 44592578)
-
(2006)
Clinical Immunology
, vol.121
, Issue.2
, pp. 144-158
-
-
Daniels, T.R.1
Delgado, T.2
Rodriguez, J.A.3
Helguera, G.4
Penichet, M.L.5
-
136
-
-
78349298744
-
Leukemia-Specific siRNA Delivery by Immunonanoplexes Consisting of Anti-JL1 Minibody Conjugated to Oligo-9 Arg-Peptides
-
Lee YK, Kim KS, Kim JS, et al. Leukemia-Specific siRNA Delivery by Immunonanoplexes Consisting of Anti-JL1 Minibody Conjugated to Oligo-9 Arg-Peptides. Mol Cells 2010;29:457-62
-
(2010)
Mol Cells
, vol.29
, pp. 457-62
-
-
Lee, Y.K.1
Kim, K.S.2
Kim, J.S.3
-
137
-
-
0032174960
-
Immunotherapeutic potential of JL1, a thymocyte surface protein, for leukemia
-
Kim TJ, Park SH. Immunotherapeutic potential of JL1, a thymocyte surface protein, for leukemia. J Korean Med Sci 1998;13:455-8 (Pubitemid 128686233)
-
(1998)
Journal of Korean Medical Science
, vol.13
, Issue.5
, pp. 455-458
-
-
Kim, T.J.1
Park, S.H.2
-
138
-
-
17344366564
-
A cell surface molecule, JL1; A specific target for diagnosis and treatment of leukemias
-
Park WS, Bae YM, Chung DH, et al. A cell surface molecule, JL1; a specific target for diagnosis andtreatment of leukemias. Leukemia 1998;12:1583-90 (Pubitemid 28470443)
-
(1998)
Leukemia
, vol.12
, Issue.10
, pp. 1583-1590
-
-
Park, W.S.1
Bae, Y.M.2
Chung, D.H.3
Kim, T.J.4
Choi, E.Y.5
Chung, J.-K.6
Lee, M.C.7
Park, S.Y.8
Park, M.H.9
Park, S.H.10
-
139
-
-
0043160581
-
Targeted cytotoxic effect of anti-JL1 immunotoxin against a human leukemic cell line and its clinical implications
-
DOI 10.1007/s00262-003-0374-y
-
Shin YK, Choi YL, Choi EY, et al. Targeted cytotoxic effect of anti-JL1 immunotoxin against a human leukemic cell line and its clinical implications. Cancer Immunol Immunother 2003;52:506-12 (Pubitemid 36963212)
-
(2003)
Cancer Immunology, Immunotherapy
, vol.52
, Issue.8
, pp. 506-512
-
-
Shin, Y.K.1
Choi, Y.L.2
Choi, E.Y.3
Kim, M.K.4
Kook, M.-C.5
Chung, J.6
Choi, Y.-K.7
Kim, H.S.8
Song, H.G.9
Park, S.H.10
-
140
-
-
33645823860
-
Efficient nonviral gene delivery into primary lymphocytes from rats and mice
-
DOI 10.1096/fj.05-4651fje
-
Goffinet C, Keppler OT. Efficient nonviral gene delivery into primary lymphocytes from rats and mice. FASEB J 2006;20:500-2 (Pubitemid 46671229)
-
(2006)
FASEB Journal
, vol.20
, Issue.3
, pp. 500-502
-
-
Goffinet, C.1
Keppler, O.T.2
-
141
-
-
35848935409
-
Intravenous siRNA of brain cancer with receptor targeting and avidin-biotin technology
-
DOI 10.1007/s11095-007-9460-8
-
Xia CF, Zhang Y, Zhang Y, et al. Intravenous siRNA of brain cancer with receptor targeting and avidin-biotin technology. Pharm Res 2007;24:2309-16 (Pubitemid 350060723)
-
(2007)
Pharmaceutical Research
, vol.24
, Issue.12
, pp. 2309-2316
-
-
Xia, C.-F.1
Zhang, Y.2
Zhang, Y.3
Boado, R.J.4
Pardridge, W.M.5
-
142
-
-
14544298301
-
Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle
-
Schiffelers RM, Ansari A, Xu J, et al. Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle. Nucleic Acids Res 2004;32:1-10
-
(2004)
Nucleic Acids Res
, vol.32
, pp. 1-10
-
-
Schiffelers, R.M.1
Ansari, A.2
Xu, J.3
-
143
-
-
77349095284
-
Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab
-
Hobel S, Koburger I, John M, et al. Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab. J Gene Med 2010;12:287-300
-
(2010)
J Gene Med
, vol.12
, pp. 287-300
-
-
Hobel, S.1
Koburger, I.2
John, M.3
-
144
-
-
46349111796
-
Poly(ester amine)-mediated, aerosol-delivered Akt1 small interfering RNA suppresses lung tumorigenesis
-
DOI 10.1164/rccm.200707-1022OC
-
Xu CX, Jere D, Jin H, et al. Poly(ester amine)-mediated, aerosol-delivered Akt1 small interfering RNA suppresses lung tumorigenesis. Am J Respir Crit Care Med 2008;178:60-73 (Pubitemid 351919194)
-
(2008)
American Journal of Respiratory and Critical Care Medicine
, vol.178
, Issue.1
, pp. 60-73
-
-
Xu, C.-X.1
Jere, D.2
Jin, H.3
Chang, S.-H.4
Chung, Y.-S.5
Shin, J.-Y.6
Kim, J.-E.7
Park, S.-J.8
Lee, Y.-H.9
Chae, C.-H.10
Lee, K.H.11
Beck Jr., G.R.12
Cho, C.-S.13
Cho, M.-H.14
-
145
-
-
33746267422
-
RNA interference-mediated gene silencing of pleiotrophin through polyethylenimine-complexed small interfering RNAs in vivo exerts antitumoral effects in glioblastoma xenografts
-
DOI 10.1089/hum.2006.17.751
-
Grzelinski M, Urban-Klein B, Martens T, et al. RNA interference-mediated gene silencing of pleiotrophin through polyethylenimine-complexed small interfering RNAs in vivo exerts antitumoral effects in glioblastoma xenografts. Hum Gene Ther 2006;17:751-66 (Pubitemid 44100720)
-
(2006)
Human Gene Therapy
, vol.17
, Issue.7
, pp. 751-766
-
-
Grzelinski, M.1
Urban-Klein, B.2
Martens, T.3
Lamszus, K.4
Bakowsky, U.5
Hobel, S.6
Czubayko, F.7
Aigner, A.8
-
146
-
-
72149101228
-
The induction of tumor apoptosis in B16 melanoma following STAT3 siRNA delivery with a lipid-substituted polyethylenimine
-
Alshamsan A, Hamdy S, Samuel J, et al. The induction of tumor apoptosis in B16 melanoma following STAT3 siRNA delivery with a lipid-substituted polyethylenimine. Biomaterials 2010;31:1420-8
-
(2010)
Biomaterials
, vol.31
, pp. 1420-8
-
-
Alshamsan, A.1
Hamdy, S.2
Samuel, J.3
-
147
-
-
23844474160
-
Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors
-
DOI 10.1038/nbt1101
-
Song E, Zhu P, Lee SK, et al. Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors. Nat Biotechnol 2005;23:709-17 (Pubitemid 41716361)
-
(2005)
Nature Biotechnology
, vol.23
, Issue.6
, pp. 709-717
-
-
Song, E.1
Zhu, P.2
Lee, S.-K.3
Chowdhury, D.4
Kussman, S.5
Dykxhoorn, D.M.6
Feng, Y.7
Palliser, D.8
Weiner, D.B.9
Shankar, P.10
Marasco, W.A.11
Lieberman, J.12
-
148
-
-
72149099569
-
The systemic delivery of siRNAs by a cell penetrating peptide, low molecular weight protamine
-
Choi YS, Lee JY, Suh JS, et al. The systemic delivery of siRNAs by a cell penetrating peptide, low molecular weight protamine. Biomaterials 2010;31:1429-43
-
(2010)
Biomaterials
, vol.31
, pp. 1429-43
-
-
Choi, Y.S.1
Lee, J.Y.2
Suh, J.S.3
-
149
-
-
34347272315
-
Administration in non-human primates of escalating intravenous doses of targeted nanoparticles containing ribonucleotide reductase subunit M2 siRNA
-
DOI 10.1073/pnas.0701458104
-
Heidel JD, Yu Z, Liu JY, et al. Administration in nonhuman primates of escalating intravenous doses of targeted nanoparticles containing ribonucleotide reductase subunit M2 siRNA. Proc Natl Acad Sci USA 2007;104:5715-21 (Pubitemid 47175600)
-
(2007)
Proceedings of the National Academy of Sciences of the United States of America
, vol.104
, Issue.14
, pp. 5715-5721
-
-
Heidel, J.D.1
Yu, Z.2
Liu, J.Y.-C.3
Rele, S.M.4
Liang, Y.5
Zeidan, R.K.6
Kornbrust, D.J.7
Davis, M.E.8
-
150
-
-
25444482607
-
Sequence-specific knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of metastatic Ewing's sarcoma
-
DOI 10.1158/0008-5472.CAN-05-0565
-
Hu-Lieskovan S, Heidel JD, Bartlett DW, et al. Sequence-specific knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of metastatic Ewing's sarcoma. Cancer Res 2005;65:8984-92 (Pubitemid 41377390)
-
(2005)
Cancer Research
, vol.65
, Issue.19
, pp. 8984-8992
-
-
Hu-Lieskovan, S.1
Heidel, J.D.2
Bartlett, D.W.3
Davis, M.E.4
Triche, T.J.5
-
151
-
-
34848918210
-
Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging
-
Bartlett DW, Su H, Hildebrant IJ, et al. Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging. Proc Natl Acad Sci USA 2007;104:15549-15
-
(2007)
Proc Natl Acad Sci USA
, vol.104
, pp. 15549-15
-
-
Bartlett, D.W.1
Su, H.2
Hildebrant, I.J.3
-
152
-
-
2442668068
-
A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics
-
DOI 10.1158/0008-5472.CAN-03-2682
-
Takei Y, Kadomatsu K, Yuzawa Y, et al. A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics. Cancer Res 2004;64:3365-70 (Pubitemid 38657905)
-
(2004)
Cancer Research
, vol.64
, Issue.10
, pp. 3365-3370
-
-
Takei, Y.1
Kadomatsu, K.2
Yuzawa, Y.3
Matsuo, S.4
Muramatsu, T.5
-
153
-
-
24744464786
-
Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo
-
DOI 10.1073/pnas.0501753102
-
Takeshita F, Minakuchi Y, Nagahara S, et al. Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo. Proc Natl Acad Sci USA 2005;102:12177-82 (Pubitemid 41291148)
-
(2005)
Proceedings of the National Academy of Sciences of the United States of America
, vol.102
, Issue.34
, pp. 12177-12182
-
-
Takeshita, F.1
Minakuchi, Y.2
Nagahara, S.3
Honma, K.4
Sasaki, H.5
Hirai, K.6
Teratani, T.7
Namatame, N.8
Yamamoto, Y.9
Hanai, K.10
Kato, T.11
Sano, A.12
Ochiya, T.13
-
154
-
-
33745625836
-
Therapeutic potential of RNA interference against cancer
-
DOI 10.1111/j.1349-7006.2006.00234.x
-
Takeshita F, Ochiya T. Therapeutic potential of RNA interference against cancer. Cancer Sci 2006;97:689-96 (Pubitemid 43983779)
-
(2006)
Cancer Science
, vol.97
, Issue.8
, pp. 689-696
-
-
Takeshita, F.1
Ochiya, T.2
-
155
-
-
3242733298
-
Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo
-
Minakuchi Y, Takeshita F, Kosaka N, et al. Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo. Nucleic Acids Res 2004;32:1-7
-
(2004)
Nucleic Acids Res
, vol.32
, pp. 1-7
-
-
Minakuchi, Y.1
Takeshita, F.2
Kosaka, N.3
-
156
-
-
67649295505
-
SiRNA delivery systems for cancer treatment
-
Oh YK, Park TG. siRNA delivery systems for cancer treatment. Adv Drug Deliv Rev 2009;61:850-62
-
(2009)
Adv Drug Deliv Rev
, vol.61
, pp. 850-62
-
-
Oh, Y.K.1
Park, T.G.2
-
157
-
-
0022858683
-
A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs
-
Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 1986;46:6387-92 (Pubitemid 17221789)
-
(1986)
Cancer Research
, vol.46
, Issue.12
, pp. 6387-6392
-
-
Matsumura, Y.1
Maeda, H.2
-
158
-
-
78449309070
-
Efficient and targeted delivery of siRNA in vivo
-
Shim MS, Kwon YJ. Efficient and targeted delivery of siRNA in vivo. FEBS J 2010;277:4814-27
-
(2010)
FEBS J
, vol.277
, pp. 4814-27
-
-
Shim, M.S.1
Kwon, Y.J.2
-
159
-
-
0026042013
-
r protein kinase in a cell-free system
-
Katze MG, Wambach M, Wong ML, et al. Functional expression and RNA binding analysis of the interferon-induced, double-stranded RNA-activated, 68,000-Mr protein kinase in a cell-free system. Mol Cell Biol 1991;11:5497-505 (Pubitemid 21895315)
-
(1991)
Molecular and Cellular Biology
, vol.11
, Issue.11
, pp. 5497-5505
-
-
Katze, M.G.1
Wambach, M.2
Wong, M.-L.3
Garfinkel, M.4
Meurs, E.5
Chong, K.6
Williams, B.R.G.7
Hovanessian, A.G.8
Barber, G.N.9
-
160
-
-
0035909372
-
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
-
DOI 10.1038/35099560
-
Alexopoulou L, Holt AC, Medzhitov R, et al. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001;413:732-8 (Pubitemid 33009951)
-
(2001)
Nature
, vol.413
, Issue.6857
, pp. 732-738
-
-
Alexopoulou, L.1
Holt, A.C.2
Medzhitov, R.3
Flavell, R.A.4
|